Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T12:45:22.081Z.
Calculation as of: 2026-10-06T12:45:22.081Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 473da95602fdb42a5f780e5c02853506da999e38a33e04168dea7648cb5c925f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-10-31.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
EV/ASSETS RATIO AVG TTM
N/A
EV/ASSETS RATIO AVG 3Y
N/A
EV/ASSETS RATIO AVG 5Y
N/A
EV/ASSETS RATIO AVG 10Y
N/A
EV/ASSETS RATIO AVG 15Y
N/A
EV/ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$67.11M
EV/Assets Ratio
7.48x
TTM Avg
1.40x
3Y Avg
1.27x
5Y Avg
1.51x
Market Cap
$65.08M
EV/Assets Ratio
0.82x
TTM Avg
2.24x
3Y Avg
1.66x
5Y Avg
1.81x
Market Cap
$69.05M
EV/Assets Ratio
2.27x
TTM Avg
2.83x
3Y Avg
3.09x
5Y Avg
3.04x
Market Cap
$69.43M
EV/Assets Ratio
N/A
TTM Avg
0.41x
3Y Avg
0.28x
5Y Avg
0.26x
Market Cap
$70.01M
EV/Assets Ratio
5.43x
TTM Avg
3.86x
3Y Avg
1.85x
5Y Avg
1.69x
Market Cap
$70.03M
EV/Assets Ratio
0.78x
TTM Avg
1.07x
3Y Avg
1.72x
5Y Avg
1.78x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alps Group Inc (ALPS) | $66.56M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $67.11M | 7.48x | 1.40x | 1.27x | 1.51x |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | 0.82x | 2.24x | 1.66x | 1.81x |
| InterCure Ltd. (INCR)vs › | $64.56M | 0.50x | 0.45x | 0.53x | 0.65x |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | 2.27x | 2.83x | 3.09x | 3.04x |
| Cingulate Inc. (CING)vs › | $63.98M | 1.27x | 1.40x | 4.90x | 17.42x |
| Fortress Biotech, Inc. (FBIO)vs › | $69.43M | N/A | 0.41x | 0.28x | 0.26x |
| MindWalk Holdings Corp. (HYFT)vs › | $70.01M | 5.43x | 3.86x | 1.85x | 1.69x |
| Heron Therapeutics, Inc. (HRTX)vs › | $70.03M | 0.78x | 1.07x | 1.72x | 1.78x |
| iBio, Inc. (IBIO)vs › | $72.02M | 0.18x | 1.64x | 0.92x | 0.73x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/ASSETS RATIO |
|---|---|
| 2025-10-31 | 3.12x |
| 2025-10-30 | 3.54x |
| 2025-10-28 | 11.75x |
| 2025-10-27 | 12.24x |
